Renalytix AI plc (LON:RENX)
1.80p
Spriggl Score: Moderate— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“FDA-approved kidney test faces binary survival bet; massive cash burn demands rapid sales scale.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Renalytix AI plc
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines v…
- Sector:
- Healthcare
- Industry:
- Health Information Services
- Market Cap:
- £7.9M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Renalytix AI plc and 1,600+ UK and US stocks.
Start free